$TER

Poulin Shannon John sold $348K of TER

Poulin Shannon John (President, Semiconductor Test) sold 1,008 shares of TERADYNE, INC (TER) at $345.37 ($0.35M total) on 2026-05-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Poulin Shannon John
Published May 26, 2026, 9:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 9:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TER
Neutral
high confidence
Mentioned
$TER
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TERNeutralLow
01

Why it matters

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it is generally treated as routine and lower informational content; therefore, trading impact should be limited absent other catalysts.

02

Market read

A single executive 10b5-1 sale is unlikely to materially change Teradyne’s valuation outlook on its own.

03

What to watch

Check for clustering of insider transactions around earnings or guidance windows; this brief only covers one Form 4 event.

Relevance 6/10Timing: Filed 2026-05-26 for a sale dated 2026-05-21; any price effect would be confined to the filing window.

Background

The article is an SEC Form 4 disclosure of an officer/direct sale of Teradyne shares, including that it was executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$TERNeutralHigh confidence
Context

Teradyne president sold 1,008 shares in an open-market transaction under a pre-arranged 10b5-1 plan, signaling routine insider liquidity rather than new fundamentals.

Expected impact

Limited near-term impact; any reaction is likely to fade unless accompanied by other company-specific news.

Evidence & confidence

The filing is a scheduled 10b5-1 sale (pre-arranged plan) with no accompanying operational or financial disclosure in the article.

Market effects

Minimal; insider liquidity in semiconductor test equipment does not change sector demand expectations by itself.

None indicated; this is a US insider transaction disclosure.

None indicated; no international deal/regulatory development mentioned.

Counterpoint

Even with 10b5-1, repeated insider selling can be interpreted as caution by insiders, though the article provides no pattern beyond this single sale.

Key entities

  • TERADYNE, INC

    Company whose officer executed an open-market sale of shares under a pre-arranged 10b5-1 plan.

  • Poulin Shannon John

    President, Semiconductor Test; reported direct sale of 1,008 shares.

Related articles

$TERMed

5 Revealing Analyst Questions From Teradyne’s Q2 Earnings Call

Teradyne reported Q2 revenue of $1.33B vs $1.22B expected and adjusted EPS of $2.47 vs $2.05, citing AI-driven demand across semiconductor test, product test, and robotics. CEO Gregory Smith said over 60% of revenue is AI-related. Q3 guidance calls for $1.25B revenue and $2.00 adjusted EPS at midpoint. Analysts asked about test equipment share, wafer-to-data-center strategy, memory drivers, and CPU vs GPU testing.

$TERMedAI 8/10

Why Teradyne Stock Is Gaining Today

Teradyne (NASDAQ: TER) shares rose about 3.3% midday after Q2 results and guidance beat expectations. The company reported non-GAAP EPS of $2.47 on revenue of $1.33B, topping analyst forecasts by $0.42 and about $110M, respectively. Q3 guidance calls for revenue $1.2B to $1.3B and adjusted EPS $1.85 to $2.15, both above estimates, though gains eased amid broader macro concerns.

$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

$TERMed

Why Teradyne (TER) Stock Is Trading Up Today

Teradyne (NASDAQ: TER) shares rose about 12.5% after the company reported strong Q2 results. Revenue was about $1.3 billion, more than double year over year, driven by demand for AI test equipment. Management said AI-related orders now exceed 60% of the business. The move followed broader semiconductor weakness tied to China and AI demand concerns.

$TERMedAI 8/10

Why Teradyne Stock Is Gaining Today

Teradyne shares rose 3.3% around 1 p.m. ET despite declines in the S&P 500 and Nasdaq. After reporting Q2 results, the company posted non-GAAP EPS of $2.47 on revenue of $1.33B, beating analyst expectations, and provided Q3 guidance of $1.2B to $1.3B revenue and $1.85 to $2.15 adjusted EPS.